Respiratory
Boehringer Ingelheim has over 95 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
Progressive fibrosing ILD
Progressive fibrosing ILD (PF-ILD) describes a disease behaviour observed in some patients across different Interstitial Lung Diseases (ILD). ILDs are a group of different diseases that affect the lace-like network of tissue and space around the air sacs of the lungs (interstitium). In some patients with ILD, there is a build-up of scar tissue in the lungs that keeps worsening. The lungs becoming progressively scarred, thickened and stiff leads to worsening of lung function, respiratory symptoms and worsening of health-related quality of life. Idiopathic pulmonary fibrosis (IPF) is considered the most typical example of PF-ILD.
-
Journeys through pulmonary fibrosis
Progressive fibrosing ILD
As we speak to the pulmonary fibrosis community, we hear stories of determination and spirit. Click here to access the podcast series.
-
Pulmonary Fibrosis Awareness Month 2020
Progressive fibrosing ILD
Peter Fang describes our commitment to people with pulmonary fibrosis
-
Life with pulmonary fibrosis
Progressive fibrosing ILD and IPF
Life with Pulmonary Fibrosis supports you to learn more about your condition and connect you with resources to help you and your loved ones
-
Progressive Fibrosing ILD Infographic
DOWNLOAD PDF (792.16 KB)
Facts and information about Progressive Fibrosing Interstitial Lung Disease